Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly: for all, none, or which patients?

Cancer. 2011 Sep 1;117(17):3879-81. doi: 10.1002/cncr.25934. Epub 2011 Feb 1.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Azacitidine / administration & dosage
  • Azacitidine / analogs & derivatives
  • Clinical Trials as Topic
  • DNA Methylation*
  • DNA Modification Methylases / antagonists & inhibitors
  • Decitabine
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Middle Aged
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Decitabine
  • DNA Modification Methylases
  • Azacitidine